Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience

BACKGROUND: Recent evidence has raised concerns regarding the safety of the everolimus-eluting bioresorbable vascular scaffold (E-BVS) (Absorb, Abbott Vascular, Santa Clara, CA, USA). Following these data, the use of this device has diminished in the Netherlands; however, daily practice data are lim...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neth Heart J
Autori principali: Remkes, W. S., Hermanides, R. S., Kennedy, M. W., Fabris, E., Kaplan, E., Ottervanger, J. P., van ’t Hof, A. W. J., Kedhi, E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Bohn Stafleu van Loghum 2017
Soggetti:
Original Article - E‑Learning
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5653537/
https://ncbi.nlm.nih.gov/pubmed/28913627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-017-1038-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi